Ancient chinese practice tested to ease lupus fatigue and stress
NCT ID NCT02732470
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether practicing Qi Gong, a gentle mind-body exercise, could improve quality of life in people with systemic lupus erythematosus (SLE). Thirty-three participants took part in weekly Qi Gong sessions for six months. Researchers measured changes in physical function, fatigue, and mood to see if this ancient practice helps manage lupus symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Qi Gong (mind-body practice involving gentle movements, postures, and breathing)
- What this could lead to
- If it works, this could offer a safe, drug-free way to improve daily life and well-being for people with lupus.
- What could go wrong
- This is a small, early study with only 33 participants and no comparison group, so results may not be reliable or apply to everyone. The benefit may be small or due to a placebo effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Apr 2016
- Finished
-
Oct 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of Systemic Lupus Erythematosus (SLE) according the American Rheumatology Association (ARA) and/or Systemic Lupus International Collaborating Clinics (SLICC) Criteria * Free and Clarified Consent Term signature. Exclusion Criteria: * Patients who have other rheumatologic diseases (rheumatoid arthritis, sjogren syndrome, fibromyalgia, ankylosis spondylitis); * Systemic Lupus Erythematosus Disease Assessment Index (SLEDAI) \> 5; * Patients with malignancy; * Patients who do not accept the study rules as time and/or follow-up exercise program time proposed; * Suspected or pregnancy confirmation; * Patients with Inability or unwillingness to understand and/or sign informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lupus erythematosus, systemic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Limoges
Limoges, 87042, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe why rheumatic pain feels different for everyone
- Ear-Zapping device may quiet lupus pain and fatigue
- Can a weekly dipstick at home catch lupus kidney damage early?
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Can a blood test catch lupus flares earlier?
- Can one pill tame four autoimmune diseases? a Long-Term trial puts it to the test